Loading...
Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease
BACKGROUND AND AIMS: Reactive testing has emerged as the new standard of care for managing loss of response to infliximab in inflammatory bowel disease [IBD]. Recent data suggest that proactive infliximab monitoring is associated with better therapeutic outcomes in IBD. Nevertheless, there are no da...
Na minha lista:
| Udgivet i: | J Crohns Colitis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7189980/ https://ncbi.nlm.nih.gov/pubmed/29590345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjy039 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|